| Sandoz Pharmaceuticals AG - Pazopanib Sandoz 400 mg, Filmtabletten | | 69994 | | 02 | | Pazopanib Sandoz 400 mg | | Filmtabletten | | L01EX03 | | Pazopanib | | 23.06.2025 | | |
| | Composition | | pazopanibum 400 mg ut pazopanibi hydrochloridum 433.4 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 171, pro compresso obducto corresp. natrium 2.34 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Pazopanibum | 400 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 | PR | PR | A | | No |
|
|
